These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 20392215)

  • 1. Zinc finger protein 521, a new player in bone formation.
    Hesse E; Kiviranta R; Wu M; Saito H; Yamana K; Correa D; Atfi A; Baron R
    Ann N Y Acad Sci; 2010 Mar; 1192():32-7. PubMed ID: 20392215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zfp521 antagonizes Runx2, delays osteoblast differentiation in vitro, and promotes bone formation in vivo.
    Wu M; Hesse E; Morvan F; Zhang JP; Correa D; Rowe GC; Kiviranta R; Neff L; Philbrick WM; Horne WC; Baron R
    Bone; 2009 Apr; 44(4):528-36. PubMed ID: 19095088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zfp521 controls bone mass by HDAC3-dependent attenuation of Runx2 activity.
    Hesse E; Saito H; Kiviranta R; Correa D; Yamana K; Neff L; Toben D; Duda G; Atfi A; Geoffroy V; Horne WC; Baron R
    J Cell Biol; 2010 Dec; 191(7):1271-83. PubMed ID: 21173110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of bone development and extracellular matrix protein genes by RUNX2.
    Komori T
    Cell Tissue Res; 2010 Jan; 339(1):189-95. PubMed ID: 19649655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BMP-2 promotes differentiation of osteoblasts and chondroblasts in Runx2-deficient cell lines.
    Liu T; Gao Y; Sakamoto K; Minamizato T; Furukawa K; Tsukazaki T; Shibata Y; Bessho K; Komori T; Yamaguchi A
    J Cell Physiol; 2007 Jun; 211(3):728-35. PubMed ID: 17226753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Runx1/AML1 hematopoietic transcription factor contributes to skeletal development in vivo.
    Lian JB; Balint E; Javed A; Drissi H; Vitti R; Quinlan EJ; Zhang L; Van Wijnen AJ; Stein JL; Speck N; Stein GS
    J Cell Physiol; 2003 Aug; 196(2):301-11. PubMed ID: 12811823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in Runx2 regulation and its isoforms.
    Li YL; Xiao ZS
    Med Hypotheses; 2007; 68(1):169-75. PubMed ID: 16901655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Core-binding factor beta interacts with Runx2 and is required for skeletal development.
    Yoshida CA; Furuichi T; Fujita T; Fukuyama R; Kanatani N; Kobayashi S; Satake M; Takada K; Komori T
    Nat Genet; 2002 Dec; 32(4):633-8. PubMed ID: 12434152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mechanism of transcriptional regulation by Runx2 in osteoblasts].
    Komori T
    Clin Calcium; 2006 May; 16(5):801-7. PubMed ID: 16679622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A local bone anabolic effect of rhFGF2-impregnated gelatin hydrogel by promoting cell proliferation and coordinating osteoblastic differentiation.
    Kodama N; Nagata M; Tabata Y; Ozeki M; Ninomiya T; Takagi R
    Bone; 2009 Apr; 44(4):699-707. PubMed ID: 19166987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Requisite roles of Runx2 and Cbfb in skeletal development.
    Komori T
    J Bone Miner Metab; 2003; 21(4):193-7. PubMed ID: 12811622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hand2 controls osteoblast differentiation in the branchial arch by inhibiting DNA binding of Runx2.
    Funato N; Chapman SL; McKee MD; Funato H; Morris JA; Shelton JM; Richardson JA; Yanagisawa H
    Development; 2009 Feb; 136(4):615-25. PubMed ID: 19144722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone attenuates the transcriptional activity of Runx2 by facilitating its physical association with Stat3beta.
    Ziros PG; Georgakopoulos T; Habeos I; Basdra EK; Papavassiliou AG
    J Bone Miner Res; 2004 Nov; 19(11):1892-904. PubMed ID: 15476590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative regulation of the osteoblast function in multiple myeloma through the repressor gene E4BP4 activated by malignant plasma cells.
    Silvestris F; Cafforio P; De Matteo M; Calvani N; Frassanito MA; Dammacco F
    Clin Cancer Res; 2008 Oct; 14(19):6081-91. PubMed ID: 18829486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zinc deficiency suppresses matrix mineralization and retards osteogenesis transiently with catch-up possibly through Runx 2 modulation.
    Kwun IS; Cho YE; Lomeda RA; Shin HI; Choi JY; Kang YH; Beattie JH
    Bone; 2010 Mar; 46(3):732-41. PubMed ID: 19913120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct transcriptional repression of Zfp423 by Zfp521 mediates a bone morphogenic protein-dependent osteoblast versus adipocyte lineage commitment switch.
    Addison WN; Fu MM; Yang HX; Lin Z; Nagano K; Gori F; Baron R
    Mol Cell Biol; 2014 Aug; 34(16):3076-85. PubMed ID: 24891617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ets transcription factors and targets in osteogenesis.
    Raouf A; Seth A
    Oncogene; 2000 Dec; 19(55):6455-63. PubMed ID: 11175361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteoclast inhibitory lectin (OCIL) inhibits osteoblast differentiation and function in vitro.
    Nakamura A; Ly C; Cipetić M; Sims NA; Vieusseux J; Kartsogiannis V; Bouralexis S; Saleh H; Zhou H; Price JT; Martin TJ; Ng KW; Gillespie MT; Quinn JM
    Bone; 2007 Feb; 40(2):305-15. PubMed ID: 17049328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression of runx2, Osterix, c-fos, DLX-3, DLX-5, and MSX-2 in dental follicle cells during osteogenic differentiation in vitro.
    Morsczeck C
    Calcif Tissue Int; 2006 Feb; 78(2):98-102. PubMed ID: 16467978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes.
    Hill TP; Später D; Taketo MM; Birchmeier W; Hartmann C
    Dev Cell; 2005 May; 8(5):727-38. PubMed ID: 15866163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.